Compile Data Set for Download or QSAR
maximum 50k data
Found 43 Enz. Inhib. hit(s) with all data for entry = 10638
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556317(US11345702, Table 1.35 | US20230390274, Compound A...)
Affinity DataIC50:  0.5nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556286(US11345702, Table 1.4 | US20230390274, Compound A-...)
Affinity DataIC50:  0.600nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556308(US11345702, Table 1.26 | US20230390274, Compound A...)
Affinity DataIC50:  1.5nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556300(US11345702, Table 1.18 | US20230390274, Compound A...)
Affinity DataIC50:  1.80nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556287(US11345702, Table 1.5 | US20230390274, Compound A-...)
Affinity DataIC50:  2.5nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM50445521(CHEMBL3103033 | US11345702, Table 1.21 | US2023039...)
Affinity DataIC50:  2.70nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556325(US11345702, Table 2.8 | US20230390274, Compound A-...)
Affinity DataIC50:  3.10nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556313(US11345702, Table 1.31 | US20230390274, Compound A...)
Affinity DataIC50:  3.10nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556306(US11345702, Table 1.24 | US20230390274, Compound A...)
Affinity DataIC50:  3.20nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556299(US11345702, Table 1.17 | US20230390274, Compound A...)
Affinity DataIC50:  5.20nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556294(US11345702, Table 1.12 | US20230390274, Compound A...)
Affinity DataIC50:  5.60nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556298(US11345702, Table 1.16 | US20230390274, Compound A...)
Affinity DataIC50:  5.70nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556316(US11345702, Table 1.34 | US20230390274, Compound A...)
Affinity DataIC50:  5.80nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM50445514(CHEMBL3103040 | US11345702, Table 1.33 | US2023039...)
Affinity DataIC50:  6.40nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556320(US11345702, Table 2.3 | US20230390274, Compound A-...)
Affinity DataIC50:  8.5nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556309(US11345702, Table 1.27 | US20230390274, Compound A...)
Affinity DataIC50:  10.6nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556301(US11345702, Table 1.19 | US20230390274, Compound A...)
Affinity DataIC50:  12.2nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556311(US11345702, Table 1.29 | US20230390274, Compound A...)
Affinity DataIC50:  12.8nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556322(US11345702, Table 2.5 | US20230390274, Compound A-...)
Affinity DataIC50:  18.6nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556284(US11345702, Table 1.2 | US20230390274, Compound A-...)
Affinity DataIC50:  19.5nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556285(US11345702, Table 1.3 | US20230390274, Compound A-...)
Affinity DataIC50:  20.1nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556307(US11345702, Table 1.25 | US20230390274, Compound A...)
Affinity DataIC50:  24.9nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556323(US11345702, Table 2.6 | US20230390274, Compound A-...)
Affinity DataIC50:  27.1nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556314(US11345702, Table 1.32 | US20230390274, Compound A...)
Affinity DataIC50:  43.7nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556304(US11345702, Table 1.22 | US20230390274, Compound A...)
Affinity DataIC50:  43.9nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556290(US11345702, Table 1.8 | US20230390274, Compound A-...)
Affinity DataIC50:  44.9nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556302(US11345702, Table 1.20 | US20230390274, Compound A...)
Affinity DataIC50:  46.6nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556291(US11345702, Table 1.9 | US20230390274, Compound A-...)
Affinity DataIC50:  47.1nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556312(US11345702, Table 1.30 | US20230390274, Compound A...)
Affinity DataIC50:  49.3nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556283(US11345702, Table 1.1 | US20230390274, Compound A-...)
Affinity DataIC50:  57.4nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556295(US11345702, Table 1.13 | US20230390274, Compound A...)
Affinity DataIC50:  64.7nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556305(US11345702, Table 1.23 | US20230390274, Compound A...)
Affinity DataIC50:  116nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556318(US11345702, Table 2.1 | US20230390274, Compound A-...)
Affinity DataIC50:  135nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556292(US11345702, Table 1.10 | US20230390274, Compound A...)
Affinity DataIC50:  158nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556310(US11345702, Table 1.28 | US20230390274, Compound A...)
Affinity DataIC50:  197nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556296(US11345702, Table 1.14 | US20230390274, Compound A...)
Affinity DataIC50:  274nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556319(US11345702, Table 2.2 | US20230390274, Compound A-...)
Affinity DataIC50:  277nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556297(US11345702, Table 1.15 | US20230390274, Compound T...)
Affinity DataIC50:  576nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556324(US11345702, Table 2.7 | US20230390274, Compound A-...)
Affinity DataIC50:  593nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556288(US11345702, Table 1.6 | US20230390274, Compound A-...)
Affinity DataIC50:  1.26E+3nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556321(US11345702, Table 2.4 | US20230390274, Compound A-...)
Affinity DataIC50:  2.28E+3nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556289(US11345702, Table 1.7 | US20230390274, Compound A-...)
Affinity DataIC50:  2.87E+3nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Homo sapiens (Human))
Myoforte Therapeutics

US Patent
LigandPNGBDBM556293(US11345702, Table 1.11 | US20230390274, Compound A...)
Affinity DataIC50:  4.54E+3nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent